Treatment of Epstein-Barr Virus infection in immunocompromised patients.
Pociupany M, Snoeck R, Dierickx D, Andrei G.
Biochem Pharmacol. 2024 Jul;225:116270. doi: 10.1016/j.bcp.2024.116270. Epub 2024 May 10.
Infectious Mononucleosis.
Dunmire SK, Hogquist KA, Balfour HH.
Curr Top Microbiol Immunol. 2015;390(Pt 1):211-40. doi: 10.1007/978-3-319-22822-8_9.
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.
Kerr JR.
J Clin Pathol. 2019 Oct;72(10):651-658. doi: 10.1136/jclinpath-2019-205822. Epub 2019 Jul 17.
Epstein-Barr Virus and Systemic Autoimmune Diseases.
Houen G, Trier NH.
Front Immunol. 2021 Jan 7;11:587380. doi: 10.3389/fimmu.2020.587380. eCollection 2020.
Virological Markers in Epstein-Barr Virus-Associated Diseases.
Lupo J, Truffot A, Andreani J, Habib M, Epaulard O, Morand P, Germi R.
Viruses. 2023 Feb 28;15(3):656. doi: 10.3390/v15030656.
The EB virus.
Epstein MA, Achong BG.
Annu Rev Microbiol. 1973;27:413-36. doi: 10.1146/annurev.mi.27.100173.002213.
[EB virus infection].
Kawa K.
Nihon Rinsho Meneki Gakkai Kaishi. 1996 Dec;19(6):583-7.
Asymptomatic infection with EB virus.
Sutton RN, Marston SD, Almond EJ, Reynolds K, Pounds FJ.
J Clin Pathol. 1974 Feb;27(2):97-100. doi: 10.1136/jcp.27.2.97.
Study on diagnostic value of results of EB virus nucleic acid quantification in whole blood lymphocyte and serum in children with EB virus infection.
Gao W, Wu J, Han Y, Fu X.
Cytokine. 2022 Jul;155:155902. doi: 10.1016/j.cyto.2022.155902. Epub 2022 May 10.
The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases.
Borghol AH, Bitar ER, Hanna A, Naim G, Rahal EA.
Crit Rev Microbiol. 2025 Mar;51(2):296-316. doi: 10.1080/1040841X.2024.2344114. Epub 2024 Apr 18.
